Bone-resorbing agents promote and interferon-gamma inhibits bone cell collagenase production.
Parathyroid hormone, prostaglandin E2, 1 alpha,25-dihydroxyvitamin D3, interleukin-1, tumor necrosis factor alpha, and epidermal growth factor, all known stimulators of bone resorption, markedly enhanced collagenase secretion by rat fetus osteoblastlike cells in primary culture as judged by enzyme-linked immunosorbent assay. Untreated cells contained no immunostainable or extractable collagenase. Collagenase was detected in the treated cells and media only after 1-3 h of treatment, and there was no increment in collagenase activity when cells were treated in the presence of actinomycin D or cycloheximide. Cells secreted collagenase in a latent form and also elaborated collagenase inhibitor; chromatographic separation of collagenase from collagenase inhibitor and subsequent activation of the collagenase with trypsin yielded the active species in stimulated but not in unstimulated cells. The ability of individual prostanoids, among seven tested, to promote collagenase production correlated positively with their reported capacity to promote bone resorption. Interferon-gamma (IFN-gamma), a known resorption inhibitor, blocked the increment in collagenase production caused by all agents tested. These results indicate a close linkage between stimulation of bone resorption and collagenase production by osteoblastlike cells. Various resorption stimulators, including some not previously tested for effects on collagenase, augment the de novo synthesis and secretion of collagenase and act by an IFN-gamma-inhibitable mechanism.
Shen
V
V
Department of Bone and Mineral Metabolism, Jewish Hospital at Washington University Medical Center, St. Louis, MO.
Kohler
G
G
Jeffrey
J J
JJ
Peck
W A
WA
D000818:Animals; D001862:Bone Resorption / Q000187:drug effects*; D002117:Calcitriol / Q000493:pharmacokinetics; D002478:Cells, Cultured; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D015232:Dinoprostone / Q000493:pharmacokinetics; D004306:Dose-Response Relationship, Immunologic; D004815:Epidermal Growth Factor / Q000493:pharmacokinetics; D006168:Guinea Pigs; D007371:Interferon-gamma / Q000494:pharmacology*; D007375:Interleukin-1 / Q000493:pharmacokinetics; D003012:Microbial Collagenase / Q000096:biosynthesis*; D010006:Osteoblasts / Q000201:enzymology*; D010281:Parathyroid Hormone / Q000493:pharmacokinetics; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D014409:Tumor Necrosis Factor-alpha / Q000493:pharmacokinetics
D007375:Interleukin-1; D010281:Parathyroid Hormone; D014409:Tumor Necrosis Factor-alpha; D003609:Dactinomycin; D004815:Epidermal Growth Factor; D007371:Interferon-gamma; D003012:Microbial Collagenase; D002117:Calcitriol; D015232:Dinoprostone